Arsenic trioxide is a clinical drug that can be used to successfully treat acute promyelocytic leukemia. However, its therapeutic effect on solid tumors is limited because of the poor pharmacokinetics and dose-limiting toxicity.
Zhang, Hui +12 more
core
FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF
The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
core
Acute kidney injury after treatment with arsenic trioxide. [PDF]
Najar H +4 more
europepmc +1 more source
Empagliflozin Alleviates Arsenic Trioxide-Induced Nephrotoxicity by Activating the SIRT1/Akt/Nrf2 Pathway. [PDF]
Pang C +9 more
europepmc +1 more source
Nanoliposome-Encapsulated Semiconductor Particles and Arsenic Trioxide Synergistically Enhance Chemo-Photothermal Therapy for Lung Cancer. [PDF]
He C, Wang A, Wang Y, Ma Q, Chen X.
europepmc +1 more source
Synergistic effects of arsenic trioxide and atorvastatin on proliferation and apoptosis in acute lymphoblastic leukemia cells. [PDF]
Hassanpour Khodaei S +5 more
europepmc +1 more source
An all-in-one theranostic platform for enhanced TACE: self-developing embolization with dual-targeted arsenic trioxide delivery. [PDF]
Yuan T +5 more
europepmc +1 more source
Corrosion of Carbon Steel in an Arsenic Trioxide Reduction Atmosphere Using Carbonaceous Materials for Elemental Arsenic Production. [PDF]
Long X +5 more
europepmc +1 more source
Arsenic trioxide allosterically inhibits human telomerase, validated by in-silico and in-vitro cancer and non cancer cell lines. [PDF]
Chaudhary A +8 more
europepmc +1 more source
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia. [PDF]
Dutta D +18 more
europepmc +1 more source

